Time Together: A Multi-site Nursing Intervention Project Using a Single System Experimental Design (TT)
The aim of this project is to test and evaluate a nursing intervention, Time Together (TT), created to enable quality interactions between patients and staff in psychiatric inpatient care. The research questions are:
Does TT influence the quality of interactions between staff and patients? Does TT influence patients' levels of anxiety and depressive symptoms? Does TT influence staffs' levels of perceived stress and levels of stress of conscience? Does TT influence the prevalence of coercive measures, mean length of hospital stay and the use of PRN medication?
In parallel, a process evaluation will be conducted, answering questions such as:
How do staff and patients describe their experiences of the intervention and how do contextual factors influence the effects of the intervention? What are the relationship between the outcome variables and the degree of compliance with the intended intervention? What problems are there with recruitment and dropouts?
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
BACKGROUND:
Despite the long known significance of the nurse-patient relationship, research in psychiatric inpatient care still reports on unfulfilled expectations of, and difficulties in interactions and relationships between patients and staff. As one solution to the contemporary circumstances, interventions that creates structures that allow quality interactions between patients and staff are needed.
INTERVENTION TT is an intervention, developed from the intervention Protected Engagement Time. The structure of TT is that staff, for a fixed time during the day, dedicates their time to exclusively engage with the patients. Other duties of more administrative nature, visits and meetings are organized to be performed at other times during the day. This structure will be tested at three psychiatric inpatient care wards in the north of Sweden.
DESIGN AND METHODS An experimental single system design (A-B-Follow-up) will be used. As TT will be introduced as a routine ward activity during the B phase, all patients and staff on the participating wards will be participating in TT. However, participating in the evaluation will be voluntary. Data will be collected through questionnaires once every seventh weekday during 5 weeks for the A phase, and 12 weeks during B phase.
In parallel, a process evaluation will be conducted using semi structured interviews and participating observations.
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion criteria for patients:
- 18 years or older
- Admitted to the wards during either A phase, B phase and/or follow-up
- Experience of at least one TT session is required to participate in the B phase
Exclusion criteria for patients:
- Does not master the Swedish language well enough to complete questionnaires and participate in interviews.
Inclusion criteria for staff:
- Regularly employed at the ward during A and B phase and/or follow-up.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Time Together
Time Together as described under "Interventions"
|
For a fixed time during the day, staff dedicates their time to exclusively engage with the patients.
Different activities will be offered to both patients and staff, such as playing board games, taking a walk, or having individual conversations.
Other duties of more administrative nature, visits and meetings will be performed at other times during the day.
Through this, opportunities for interaction are both created and protected.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Quality of interactions [patients]
Zeitfenster: Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
This is measured using The Caring Professional Scale (CPS) that consists of 14 items answered on a 5-point Likert scale.
|
Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
|
Perceived stress [staff]
Zeitfenster: Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
PSS consists of 10 items answered on a 5-point Likert scale
|
Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Global quality of interactions [patients, staff]
Zeitfenster: Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
A 100 mm Visual Analogue Scale expressing the most positive and the most negative rating will be anchored at each end
|
Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
|
Anxiety and depressive symptoms [patients]
Zeitfenster: Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
The Hospital Anxiety and Depression Scale (HAD) will be used to measure anxiety and depressive symptoms.
All items are scored on a 4-point scale.
|
Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
|
Stress of Conscience [staff]
Zeitfenster: Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
The Stress of Conscience Questionnaire (SCQ) will be used to measure the frequencies of stressful situations and the degree to which these lead to stress of conscience among staff.
|
Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
|
Quality of care [staff]
Zeitfenster: Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
The Quality in Psychiatric Care- Inpatient Staff (QPC-IPS) questionnaire will be used to measure quality of care.
|
Changes during baseline and intervention period (measured every seventh week day for a total of 16 weeks)
|
|
Number of PRN medications given
Zeitfenster: Changes during baseline and intervention period (measured weekly for a total of 16 weeks)
|
Data will be retrieved from ward registers.
|
Changes during baseline and intervention period (measured weekly for a total of 16 weeks)
|
|
Length of hospital stay
Zeitfenster: Changes during baseline and intervention period (measured weekly for a total of 16 weeks)
|
Data will be retrieved from ward registers.
|
Changes during baseline and intervention period (measured weekly for a total of 16 weeks)
|
|
Use of coercion and violent situations
Zeitfenster: Changes during baseline and intervention period (measured weekly for a total of 16 weeks)
|
Data will be retrieved from ward registers.
|
Changes during baseline and intervention period (measured weekly for a total of 16 weeks)
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 350000210
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .